Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa
Human Immunodeficiency Virus
About this trial
This is an interventional treatment trial for Human Immunodeficiency Virus focused on measuring Couple-based intervention, Antiretroviral therapy, South Africa
Eligibility Criteria
Inclusion Criteria:
- Both partners aged 18 or over
- HIV-positive woman diagnosed ≥ 3 months prior to study entry
- HIV-positive woman demonstrates difficulty with HIV treatment engagement, defined as either self-reported ART adherence difficulties, evidence of missed clinic visits over the past year (collected from medical records), or evidence of being not virally suppressed (≥ 50 copies/mL) in the past year
- In a committed, heterosexual, monogamous romantic relationship for at least 6 months
- Both partners willing to participate in treatment to support women's ART adherence
- Both partners reside in Vulindlela, or neighboring community, KwaZulu-Natal, South Africa
- Willing to have intervention sessions audio-recorded (if randomized to the intervention group)
- Able to comfortably communicate in either isiZulu or English
Exclusion Criteria:
- Report of moderate or severe relationship violence past year
- Either partner previously participated in a couple-based HIV prevention or treatment program
Sites / Locations
- Human Sciences Research Council
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
START Together
Standard of Care (SOC)
Couples randomized to START Together will receive the manualized treatment to enhance women's medication adherence. The treatment is 5 sessions in length and conducted weekly. Sessions are 60 - 75 minutes. Couples have the option of completing up to 3 additional booster sessions. Total treatment therefore ranges between 5 to 8 sessions.
Couples randomized to SOC will receive referrals to local HIV clinics to support medication adherence (for women) or other HIV-related issues (for men).